DPP-IV-IN-2

CAS No. 136259-18-2

DPP-IV-IN-2( H-Lys(4-nitro-Z)-pyrrolidide )

Catalog No. M26242 CAS No. 136259-18-2

DPP-IV-IN-2 is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 81 In Stock
10MG 32 In Stock
25MG 51 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DPP-IV-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    DPP-IV-IN-2 is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM).
  • Description
    DPP-IV-IN-2 is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    H-Lys(4-nitro-Z)-pyrrolidide
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    DPP
  • Recptor
    NO Synthase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    136259-18-2
  • Formula Weight
    378.429
  • Molecular Formula
    C18H26N4O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 200 mg/mL (528.51 mM)
  • SMILES
    N[C@@H](CCCCNC(=O)OCc1ccc(cc1)[N+]([O-])=O)C(=O)N1CCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kuete V, Ango PY, et al. Cytotoxicity of four Aframomum species (A. arundinaceum, A. alboviolaceum, A. kayserianum and A. polyanthum) towards multi-factorial drug resistant cancer cell lines. BMC Complement Altern Med. 2014 Sep 19;14:340.
molnova catalog
related products
  • Trelagliptin succina...

    Trelagliptin(SYR-472) is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).

  • 3-Pyridylacetic acid...

    It is an organic compunds with molecular fomula C7H8ClNO2.

  • WAY 316606

    WAY 316606 is an inhibitor of the secreted protein sFRP-1, an endogenous antagonist of the secreted glycoprotein Wnt.